Oct 1 (Reuters) - Danish drugmaker Novo Nordisk

said on Tuesday it has mitigation plans in place to

minimize or prevent any disruption to its production due to sea

port strikes in the United States.

The maker of popular drugs, Wegovy and Ozempic, plans to

ship its products to and from the U.S. via air freight, a

company spokesperson said.

The company imports some of its active pharmaceutical

ingredient, or semaglutide, into the U.S. for its blockbuster

diabetes drug Ozempic and weight-loss treatment Wegovy,

according to CNBC, which first reported on the mitigation plans.

The U.S. Department of Health and Human Services (HHS) said

earlier on Tuesday its preliminary analysis showed a strike by

U.S. East Coast and Gulf Coast dockworkers should have limited

impact on the availability of essential goods such as medicines

and medical devices.

The dockworkers began their first large-scale stoppage in

nearly 50 years, halting about half the country's ocean shipping

after negotiations for a new labor contract broke down over

wages.